NCT01568021View on ClinicalTrials.gov

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Retinal Vein OcclusionMacular Edema
Interventions
OTHER

No Intervention

No intervention was administered in this study.

Trial Locations (3)

Unknown

Glostrup Municipality

Oslo

Uppsala

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY